Officials for the FDA have expanded its’ approval of pimobendan chewable tablets (Vetmedin; Boehringer Ingelheim) to include ...

Michigan interim coach says players feel 'betrayed' after Sherrone Moore scandal ...

Up to 50 cats are expected to participate in the trial, with their weight and health metrics monitored at three and six months.

Around 70% of Americans are obese or overweight. And their cats aren’t too far off. According to the Association for Pet ...

Geneticist Michael Klotsman was frustrated by human drug development. That led him to launch a startup focused on treatments ...

Boehringer Ingelheim launched the first-ever Catvocacy Forum for the company, uniting veterinarians to elevate cat care ...

Ash-har Quraishi is a consumer correspondent based in Chicago. He is an Emmy Award-winning journalist with more than 25 years of local, national, international and investigative reporting experience.

GLP-1 drugs for pets could be the next frontier for the blockbuster weight loss and diabetes drugs. By Emily Anthes In just a few short years, new diabetes and weight loss drugs like Ozempic, Wegovy ...

Scott-Moncrieff: The most important first step is deciding which treatment is right for that individual cat, because monitoring differs depending on whether you choose insulin or an SGLT2 ...

A check mark. It indicates that the relevant content has been reviewed and verified by an expert Our stories are reviewed by medical professionals to ensure you get the most accurate and useful ...

More than half of the world's pet cats are overweight, experts estimate, and soon, these chubby felines may be treated with a drug similar to Ozempic. In a press release, pet drug company OKAVA ...